Acri Capital Acquisition Corporation logo

ACAC

NASDAQ

Acri Capital Acquisition Corporation

Acri Capital Acquisition Corporation (ACAC) is a Blank Checks company listed on NASDAQ. There were no new wire items for ACAC in the last 30 days. The most recent was published Jul 9, 2026.

News · 26 weeks10%
2026-05-17: 02026-05-24: 02026-05-31: 02026-06-07: 02026-06-14: 02026-06-21: 02026-06-28: 02026-07-05: 12026-07-12: 02026-07-19: 02026-07-26: 02026-08-02: 02026-08-09: 02026-08-16: 02026-08-23: 02026-08-30: 02026-09-06: 02026-09-13: 02026-09-20: 02026-09-27: 02026-10-04: 02026-10-11: 02026-10-18: 02026-10-25: 02026-11-01: 02026-11-08: 0
2026-05-172026-11-08
Mix090d

No activity.

Activity · 52 weeks22 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news

Latest news

25 items

ACAC FAQ

6 questions
  • What is the latest news on ACAC?
    Quantisnow has not tracked any new filings, ratings or press releases for ACAC in the last 30 days. The most recent wire item was published on July 9, 2026.
  • Where does ACAC stock trade?
    Acri Capital Acquisition Corporation (ACAC) is listed on NASDAQ.
  • What sector and industry is ACAC in?
    Acri Capital Acquisition Corporation operates in the Finance sector, Blank Checks industry.
  • When did Acri Capital Acquisition Corporation go public?
    Acri Capital Acquisition Corporation (ACAC) completed its IPO in 2022.
  • What companies are similar to ACAC?
    Notable peers in the same industry include TACO (Berto Acquisition Corp.), PRE (Prenetics Global Limited), OXSQ (Oxford Square Capital Corp.), ILLU (Illumination Acquisition Corp I), INV (Innventure Inc.). Compare ACAC side-by-side with any of them on Quantisnow.
  • How can I track ACAC on Quantisnow?
    Quantisnow aggregates Acri Capital Acquisition Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ACAC to receive live email and push alerts on every new disclosure.